Medication info
Lipitin Tablets 2 mg (Pitavastatin Calcium)

Lipitin Tablets 2 mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
Very light yellowish-red round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201103617 · Approved 2011.05.31 · Insurance code 657804710

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial dose in adults is pitavastatin calcium 1~2 mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased up to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apo-B protein
  • elevated triglycerides
View approved original text

This medication helps reduce elevated total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and increases levels of HDL cholesterol, often referred to as 'good cholesterol'. It is used as an adjunct to dietary management to control blood lipid levels. It is useful for managing hyperlipidemia and contributes to cardiovascular health. It effectively balances cholesterol levels and improves overall vascular health.

How to take

Adult dose

Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial dose in adults is pitavastatin calcium 1~2 mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased up to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to individuals who are allergic to any component of this medication, have active liver disease, or have severely impaired liver function. Additionally, patients taking cyclosporine, those with myopathy, pregnant women, women who may become pregnant, nursing mothers, and children should not use this medication. Patients with kidney dysfunction or a history of liver impairment should use this medication with caution, especially when taking fibrates or niacin, as this may lead to muscle damage and worsening kidney function. During treatment with this medication, adverse reactions such as muscle pain, weakness, abdominal pain, rash, and itching may occur, and symptoms should be reported to a physician immediately. Regular liver function tests and blood lipid checks should be performed, and if liver enzyme levels rise or muscle-related adverse effects occur, the medication should be discontinued. This medication can rarely cause severe muscle damage or liver dysfunction, thrombocytopenia, allergic reactions, etc., so immediate medical attention should be sought if these symptoms appear. Furthermore, this medication may interact with other drugs, so caution is advised when taken with cyclosporine, fibrates, niacin, erythromycin, etc. The elderly may experience side effects more easily when taking this medication, so dosage adjustment and caution are necessary. Pregnant or nursing women should not take this medication, and if pregnancy is planned or confirmed, administration should be stopped immediately. The safety and efficacy of this medication in children have not been established, hence it is not used in this population. Finally, this medication should be stored out of reach of children and in its original container to maintain quality.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • acute renal failure
Show 82 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • polyuria
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • elevated serum potassium and phosphorus
  • taste disturbances
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • sleep disorders
  • loss of appetite
  • increased blood pressure
  • chest discomfort
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that can block light and air and in a safe temperature range between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Very light yellowish-red round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.